MiniMed MMED Estimates

NASDAQ MMED
$21.79 -0.24 (-1.09%)
At close: Sep 18, 2026 · 4:00 PM EDT
Analyst Estimates

MiniMed Group, Inc. Revenue Estimates

Periods 22
Next Period Q2 26
Consensus 881.38 M

Analysts expect MiniMed Group, Inc. to report revenue of 881.38 M for Q2 26, against a range of 820.83 M to 941.94 M. The most recent reported quarter, Q1 26, came in at 843.00 M, a 1.1% miss against the 852.39 M consensus.

Metric Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 790.00 M837.00 M843.00 M--------
High Estimate 901.24 M844.43 M934.27 M941.94 M923.31 M1.06 B957.40 M911.86 M1.05 B1.06 B977.44 M
Low Estimate 762.71 M767.24 M770.51 M820.83 M859.78 M870.19 M886.82 M807.76 M924.06 M937.81 M909.08 M
Consensus Estimate 831.98 M805.84 M852.39 M881.38 M891.55 M964.21 M922.11 M859.81 M989.19 M997.25 M943.26 M
Analyst Estimates

MiniMed Group, Inc. Earnings Per Share (EPS) Estimates

Periods 22
Next Period Q1 26
Consensus 0.13

Analysts expect MiniMed Group, Inc. to report earnings per share of 0.13 for Q1 26, against a range of 0.12 to 0.14. The most recent reported quarter, Q4 25, came in at -0.68, a 385.7% miss against the -0.14 consensus.

Metric Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.16-0.68--------
High Estimate 0.19-0.130.140.160.210.290.040.120.270.40
Low Estimate 0.17-0.150.120.140.190.250.040.100.230.34
Consensus Estimate 0.18-0.140.130.150.200.270.040.110.250.37